Recent findings from the 2025 Society of Nuclear Medicine and Molecular Imaging Annual Meeting reveal the potential of a novel PET-guided radiotherapy system, SCINTIX, to enhance treatment for lung and bone tumors. Rameshwar Prasad, PhD, and colleagues demonstrated that using real-time PET signals to guide treatment planning resulted in significant reductions in tumor sizes and improved targeting, with consistent reductions in activity concentration throughout treatment fractions. The system aims to minimize healthy tissue irradiation by adapting to real-time tumor biology changes, a notable advancement over traditional imaging methods. The study's early results indicate promise but call for further trials for technical and clinical validation. Additionally, at the 2025 ASCO Annual Meeting, expert panels will present advancements in CAR T therapies, innovative treatments for small cell lung cancer, and emerging data on clinical responses in various hematologic malignancies, emphasizing ongoing progress in oncology research.
Mon, 23 Jun 2025 20:08:01 GMT | CancerNetwork